Mather Charles E Iv - Net Worth and Insider Trading

Mather Charles E Iv Net Worth

The estimated net worth of Mather Charles E Iv is at least $60,500 dollars as of 2024-06-04. Mather Charles E Iv is the Director of Eyenovia Inc and owns about 77,544 shares of Eyenovia Inc (EYEN) stock worth over $60,500. Mather Charles E Iv is also the Director of Tonix Pharmaceuticals Holding Corp and owns about 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in Mather Charles E Iv's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mather Charles E Iv has not made any transactions after 2023-05-26 and currently still holds the listed stock(s).

Transaction Summary of Mather Charles E Iv

To

Mather Charles E Iv Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mather Charles E Iv owns 2 companies in total, including Eyenovia Inc (EYEN) , and Tonix Pharmaceuticals Holding Corp (TNXP) .

Click here to see the complete history of Mather Charles E Iv’s form 4 insider trades.

Insider Ownership Summary of Mather Charles E Iv

Ticker Comapny Transaction Date Type of Owner
EYEN Eyenovia Inc 2023-05-26 director
TNXP Tonix Pharmaceuticals Holding Corp 2015-03-10 director

Mather Charles E Iv Latest Holdings Summary

Mather Charles E Iv currently owns a total of 2 stocks. Among these stocks, Mather Charles E Iv owns 77,544 shares of Eyenovia Inc (EYEN) as of May 26, 2023, with a value of $60,500 and a weighting of 100%. Mather Charles E Iv also owns 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of March 10, 2015, with a value of $0 and a weighting of 0%.

Latest Holdings of Mather Charles E Iv

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EYEN Eyenovia Inc 2023-05-26 77,544 0.78 60,500
TNXP Tonix Pharmaceuticals Holding Corp 2015-03-10 0 0.16 0

Holding Weightings of Mather Charles E Iv


Mather Charles E Iv Form 4 Trading Tracker

According to the SEC Form 4 filings, Mather Charles E Iv has made a total of 5 transactions in Eyenovia Inc (EYEN) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Eyenovia Inc is the acquisition of 3,000 shares on May 26, 2023, which cost Mather Charles E Iv around $7,470.

According to the SEC Form 4 filings, Mather Charles E Iv has made a total of 0 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 0 shares on March 10, 2015, which cost Mather Charles E Iv around $6,800.

Insider Trading History of Mather Charles E Iv

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mather Charles E Iv Trading Performance

GuruFocus tracks the stock performance after each of Mather Charles E Iv's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mather Charles E Iv is 34.31%. GuruFocus also compares Mather Charles E Iv's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mather Charles E Iv within 3 months outperforms 4 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mather Charles E Iv's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mather Charles E Iv

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
6 out of 10 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.06 LIMIT LIMIT LIMIT LIMIT LIMIT

Mather Charles E Iv Ownership Network

Ownership Network List of Mather Charles E Iv

No Data

Ownership Network Relation of Mather Charles E Iv

Insider Network Chart

Mather Charles E Iv Owned Company Details

What does Eyenovia Inc do?

Who are the key executives at Eyenovia Inc?

Mather Charles E Iv is the director of Eyenovia Inc. Other key executives at Eyenovia Inc include 10 percent owner Stuart M. Grant , director & Chief Executive Officer Michael M Rowe , and Chief Financial Officer John P Gandolfo .

Eyenovia Inc (EYEN) Insider Trades Summary

Over the past 18 months, Mather Charles E Iv made 2 insider transaction in Eyenovia Inc (EYEN) with a net purchase of 7,000. Other recent insider transactions involving Eyenovia Inc (EYEN) include a net purchase of 345,717 shares made by Stuart M. Grant , a net sale of 270,000 shares made by Tsontcho Ianchulev , and a net purchase of 17,427 shares made by Michael M Rowe .

In summary, during the past 3 months, insiders sold 0 shares of Eyenovia Inc (EYEN) in total and bought 160,717 shares, with a net purchase of 160,717 shares. During the past 18 months, 270,000 shares of Eyenovia Inc (EYEN) were sold and 389,464 shares were bought by its insiders, resulting in a net purchase of 119,464 shares.

Eyenovia Inc (EYEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eyenovia Inc Insider Transactions

No Available Data

Mather Charles E Iv Mailing Address

Above is the net worth, insider trading, and ownership report for Mather Charles E Iv. You might contact Mather Charles E Iv via mailing address: C/o Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., Suite 306, New York Ny 10022.

Discussions on Mather Charles E Iv

No discussions yet.